New York City Metropolitan Area
A global Consumer Healthcare business leader with a proven track record of steering large organizations and delivering transformational growth. Adept at managing expansive, multi‑category portfolios and fostering a culture anchored in consumer and customer centricity, resulting in sustained and differentiated performance. A strategic thinker with deep commercial acumen and a passion for developing high‑performing teams and organizations that enable enduring business success. Brings a uniquely rich set of experiences spanning several continents, multiple CPG and OTC categories, and leadership roles across several of the world’s most respected companies - Procter & Gamble, Novartis, Haleon, GSK and IQVIA Inc. ▬▬▬▬▬▬▬▬ • Empowering & Inspiring Global and Diverse Teams: Natural relationship builder and data evangelist who models ethics, integrity, and transparency. • Cross-industry experience across Healthcare (Pharma, Consumer Health, OTC, MedTech), CPG and digital & e-commerce business models. • Business Transformation & Innovations leader: driving business innovation and thought leadership by anticipating & responding to rapidly changing industry trends. • Data, AI & Analytics Expert: Transforming and shaping organizational use of advanced analytics, AI / ML technology, modern MDM, advanced data visualization and business automation. Recognized Pharma/CH/OTC industry leader and Keynote speaker US citizen residing in New Jersey and London Available @ phone: +1 973 610 3370; @email: [email protected]
Leading Global CHC advisory practice across IQVIA with a keen focus on Consumer health, OTC, Nutrition, Vitamins/Supplements, Digital healthcare and CPG verticals. Bringing together IQVIA commercial data, insight solutions, global in-depth understanding, AI/ML platforms, e-Commerce expertise and cross-functional implementation skill-set to deliver transformational results for our CHC and Nutrition clients across both Commercial and R&D. Keynote speaker and thought leader across CHC and Supplements space globally!
Driving customer-centric solutions by combining business understanding with advanced data analytics to deliver superior consumer engagement, patient outcomes, HCP targeting, innovation, etc. Delivering a $100Mio+ P&L with a direct team of 30+ Principals and an extended network of over 150 Consultants, Engagement Managers and Analysts (well distributed across both on-shore globally and off-shore in India and Poland). Highly sought after industry expert influencing strategic and data choices over an industry generating sales of over $650-900Bn per year
Global Category role with focus on doubling growth rate across key Global markets for Haleon (previously GSK Consumer). Spearheaded a global entrepreneurial team responsible for identifying and developing early/mid-stage new products opportunities (either in-house or through external partners), line extensions and new to healthcare go-to-market models. Then successfully bring them to market driven by data insights, analytics, consumer centric innovation approaches and excellence in digital marketing.
Led $500 Mio+ GSK consumer health cluster P&L consistently delivering breakthrough growth (+30% per year; 3X vs. category); market leader across several categories with brands such as Sensodyne, Parodontax, Voltaren, Theraflu, Panadol, Physiogel, Otrivin and Corega Turkey ranked among top 12 GSK CHC Global priority markets from investment and focus perspective due to its tremendous performance; Globally acknowledged for leading Turkey Sensodyne to market leadership in Oral Care category; Won GSK CEO award for Turkey performance (2015) Grew team from 50 to 320 people in just 4 years; exported talent across the region and to Global Category teams
Led 1Bn+ OTC category across North America consisting of several brands including Nicorette, Niquitin, Alli, Tums and Breathe Right Instrumental in turning-around the US Smoking Control portfolio (both sales and share gain) despite competition from Vaping and private label brands Led divestiture of tail brands portfolio including Alli, Beano, Goody’s and Fiber Choice ($210 Million Sales) to Prestige brands NA (Black-rock funded PE deal)
Led marketing for the $400 Mio+ Russia P&L, delivering +30% growth each year to become the 4th largest Novartis Consumer Health business globally Delivered on aligned commercial priorities and launched innovations across iconic brands like Theraflu, Otrivin, Voltaren, Lamisil, Fenistil and Vibrocil. Supported by a high performing team of marketers, researchers and agency partners
Led $500 Mio+ USD portfolio of Theraflu and Triaminic brands delivering global strategy, equity communication, innovation pipeline and commercial success models. Record performance across USA, Russia, CEE, Korea, Japan and India including first ever launch of Theraflu warming syrups, prevention powder and sore throat lozenges Built strong partnerships with cross-functional resources across Supply chain, R&D, Insights and Business Development leading to significant speed to market vs. competitors and ahead of market expectations